Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase II Study of GW786034 Using a Randomised Discontinuation Design in Subjects with Locally Recurrent or Metastatic Clear-Cell Renal Cell Carcinoma
pazopanib
VEG102616
NCT00244764
Carcinoma, Renal Cell
Phase 2
 
September 2013

Powered by ideaPoint, Inc.